We use cookies to customise content for your subscription and for analytics.
If you continue to browse Lexology, we will assume that you are happy to receive all our cookies. For further information please read our Cookie Policy.

Search results

Order by: most recent most popular relevance



Results: 1-10 of 715

FDA issues final rule on mica-based pearlescent pigments in distilled spirits
  • Shook Hardy & Bacon LLP
  • USA
  • October 2 2015

The U.S. Food and Drug Administration (FDA) has issued a final rule allowing "the safe use of mica-based pearlescent pigments prepared from titanium


SCCS says parabens in cosmetics are safe
  • Shook Hardy & Bacon LLP
  • European Union
  • June 13 2013

The European Union's (EU's) Scientific Committee on Consumer Safety (SCCS) has updated its opinion on propyl- and butylparabenchemical


Cosmetic Companies Continue to Receive FDA Warning Letters
  • Shook Hardy & Bacon LLP
  • USA
  • October 7 2016

The U.S. Food and Drug Administration (FDA) sent seven warning letters to cosmetics companies in September 2016, continuing the agency's trend of


Landmark Texas Supreme Court decision: learned intermediary doctrine applies in prescription drug cases, no DTC exception
  • Shook Hardy & Bacon LLP
  • USA
  • June 12 2012

Addressing the issue squarely for the first time, the Texas Supreme Court has unanimously adopted the learned intermediary doctrine in the prescription drug context thereby confirming that manufacturers are only obligated to warn doctors of the risks of prescription medicines


Does consumer awareness of food addiction affect eating behavior?
  • Shook Hardy & Bacon LLP
  • USA
  • April 24 2015

Raising concerns about how the media portrays the concept of food addiction, a new study questions whether endorsement of this model "may cause


Proposed changes to California’s Prop. 65 could expand warning label requirements
  • Shook Hardy & Bacon LLP
  • USA
  • May 7 2015

After two years of debate, the California Environmental Protection Agency's (CalEPA's) Office of Environmental Health Hazard Assess- ment may soon


French company prevails in dispute with FDA over drug-classification ruling
  • Shook Hardy & Bacon LLP
  • USA
  • October 3 2012

A federal court in the District of Columbia has determined that the Food and Drug Administration (FDA) erred when it classified a combination drug-device product as primarily a drug, thus subjecting its French manufacturer to more burdensome regulatory requirements


Prop. 65 litigation ends in agreements to remove cocamide DEA from products
  • Shook Hardy & Bacon LLP
  • USA
  • May 22 2014

According to the Center for Environmental Health (CEH), which has sued some 150 personal-care product companies for failing to warn consumers about


Cooked meats allegedly linked to increased Alzheimer’s risk
  • Shook Hardy & Bacon LLP
  • USA
  • February 28 2014

A new study has concluded that advanced glycation endproducts (AGEs), which occur in heat-processed meat and animal products, can cause brain changes


FDA's regulation of trans fats
  • Shook Hardy & Bacon LLP
  • USA
  • January 24 2014

More than 100 years after the advent of artificial trans fats, the U.S. Food and Drug Administration (FDA) has taken the first step toward banning